RW: Registration Withdrawal Request

RW：注册提款请求

美股SEC公告 · 2024/12/20 06:04

Moomoo AI 已提取核心信息

HeartSciences Inc., formerly known as Heart Test Laboratories, Inc., has requested the withdrawal of its Registration Statement on Form S-1 (File No. 333-272501) from the U.S. Securities and Exchange Commission (SEC). The request was made on December 19, 2024, pursuant to Rule 477 under the Securities Act of 1933.The Registration Statement, originally filed on June 7, 2023, had not been declared effective by the SEC. The company confirmed that no securities were issued or sold under this Registration Statement or the public offering prospectus contained therein. HeartSciences has also requested that all fees paid to the SEC in connection with the filing be credited for future use, in accordance with Rule 457(p) of the Securities Act.The withdrawal request was submitted by Danielle Watson, Chief Financial Officer of HeartSciences. The company's legal counsel, Jonathan Shechter and Sasha Ablovatskiy from Foley Shechter, are available for any further information or clarification regarding this withdrawal request.

HeartSciences Inc.，前称Heart Test Laboratories, Inc.，已请求从美国证券交易委员会（SEC）撤回其在S-1表格上的注册声明（文件编号333-272501）。该请求于2024年12月19日根据《1933年证券法》第477条提出。该注册声明最初于2023年6月7日提交，但尚未被SEC宣布有效。公司确认，此注册声明或其包含的公开发行招股说明书下没有发行或出售任何证券。HeartSciences还请求将与该申请相关的所有费用退还，以备将来使用，依据《证券法》第457(p)条。撤回请求由HeartSciences首席财务官丹妮尔·沃森提交。公司的法律顾问乔纳森·谢赫特和萨莎·阿布洛瓦茨基来自Foley Shechter，随时可以提供有关此撤回请求的进一步信息或澄清。

有用

没用

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

RW: Registration Withdrawal Request

RW: Registration Withdrawal Request

Moomoo AI 已提取核心信息

风险及免责提示

声明